Nestle India said test results from three accredited laboratories have found lead to be below permissible levels in samples of Maggi Noodles.

In a statement on Friday, Nestle India said, “We have received test results from all three laboratories mandated by the Bombay High Court to test Maggi Noodles samples. All the 90 samples, covering six variants, tested by these laboratories are clear with lead much below the permissible limits.”

This announcement saw Nestle India’s share price jump to close at ₹6,551 a piece up 5.59 per cent on Friday on the BSE.

But the trouble doesn’t end here for Nestle.

On Thursday, the National Consumer Disputes Redressal Commission, which was hearing the class action suit filed by the centre, ordered testing of 12 samples of Maggi Noodles at the Central Food Technological Research Institute in Mysuru.

In August, the Bombay High Court had directed three labs in Mohali, Jaipur, and Hyderabad to conduct re-tests on samples of the instant noodles brand.

The court had given the direction on a petition filed by Nestle India against the Food Safety and Standards Authority of India decision to ban Maggi.

“In compliance with the orders of the Bombay High Court, we will now commence manufacture and will start selling only after the newly manufactured products are also cleared by the designated three laboratories,” the company said.

The company said it is committed to re-introduce Maggi at the earliest as it will now start manufacturing.

The company reiterated that it had conducted 3,500 tests representing 200 million packs in both national and international accredited labs and all reports are clear.

It also said that it will continue to work with the FSSAI and other stakeholders.